The Rheumatologist, Cancer and the Breakthrough




Healio Rheuminations show

Summary: Checkpoint inhibitors have changed the field of oncology, as well as our understanding of autoimmunity. This episode, hosted by Leonard H. Calabrese, DO, walks us through the history of checkpoint inhibitors —from Dr. William Coley’s use of infections in cancer to the development of PD-1 inhibitors.